Citação norma APA

Tsai, C., Sun, S., Zhang, H., Local, A., Su, Y., Gross, L. A., . . . Howell, S. B. (2018). APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency. Mol Cancer Ther.

Citação norma Chicago

Tsai, Cheng-Yu, Si Sun, Hongying Zhang, Andrea Local, Yongxuan Su, Larry A. Gross, William G. Rice, and Stephen B. Howell. "APTO-253 Is a New Addition to the Repertoire of Drugs That Can Exploit DNA BRCA1/2 Deficiency." Mol Cancer Ther 2018.

Citação norma MLA

Tsai, Cheng-Yu, et al. "APTO-253 Is a New Addition to the Repertoire of Drugs That Can Exploit DNA BRCA1/2 Deficiency." Mol Cancer Ther 2018.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.